Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

Risk for hepatocellular carcinoma in patients with alcoholic cirrhosis: a Danish nationwide cohort study.

Jepsen P, Ott P, Andersen PK, Sørensen HT, Vilstrup H.

Ann Intern Med. 2012 Jun 19;156(12):841-7, W295. doi: 10.7326/0003-4819-156-12-201206190-00004.

PMID:
22711076
[PubMed - indexed for MEDLINE]
2.

Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups.

Mancebo A, González-Diéguez ML, Cadahía V, Varela M, Pérez R, Navascués CA, Sotorríos NG, Martínez M, Rodrigo L, Rodríguez M.

Clin Gastroenterol Hepatol. 2013 Jan;11(1):95-101. doi: 10.1016/j.cgh.2012.09.007. Epub 2012 Sep 13.

PMID:
22982095
[PubMed - indexed for MEDLINE]
3.

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

Bolondi L, Sofia S, Siringo S, Gaiani S, Casali A, Zironi G, Piscaglia F, Gramantieri L, Zanetti M, Sherman M.

Gut. 2001 Feb;48(2):251-9.

PMID:
11156649
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.

Charni F, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Trinchet JC, Beaugrand M, Charnaux N, Nahon P.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1439-46. doi: 10.1158/1055-9965.EPI-11-0341. Epub 2011 May 24.

PMID:
21610221
[PubMed - indexed for MEDLINE]
Free Article
5.

Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.

Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, Jackson S, Ryder S, Price A, Stein K.

Health Technol Assess. 2007 Sep;11(34):1-206. Review.

PMID:
17767898
[PubMed - indexed for MEDLINE]
Free Article
6.

Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study.

Deleuran T, Grønbaek H, Vilstrup H, Jepsen P.

Aliment Pharmacol Ther. 2012 Jun;35(11):1336-42. doi: 10.1111/j.1365-2036.2012.05091.x. Epub 2012 Apr 10.

PMID:
22490057
[PubMed - indexed for MEDLINE]
7.

Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.

Larcos G, Sorokopud H, Berry G, Farrell GC.

AJR Am J Roentgenol. 1998 Aug;171(2):433-5.

PMID:
9694470
[PubMed - indexed for MEDLINE]
8.

PNPLA3 rs738409, hepatocellular carcinoma occurrence and risk model prediction in patients with cirrhosis.

Guyot E, Sutton A, Rufat P, Laguillier C, Mansouri A, Moreau R, Ganne-Carrié N, Beaugrand M, Charnaux N, Trinchet JC, Nahon P.

J Hepatol. 2013 Feb;58(2):312-8. doi: 10.1016/j.jhep.2012.09.036. Epub 2012 Oct 13.

PMID:
23069476
[PubMed - indexed for MEDLINE]
9.

Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.

Papatheodoridis GV, Manolakopoulos S, Touloumi G, Vourli G, Raptopoulou-Gigi M, Vafiadis-Zoumbouli I, Vasiliadis T, Mimidis K, Gogos C, Ketikoglou I, Manesis EK; HEPNET. Greece Cohort Study Group.

Gut. 2011 Aug;60(8):1109-16. doi: 10.1136/gut.2010.221846. Epub 2011 Jan 26.

PMID:
21270118
[PubMed - indexed for MEDLINE]
10.

Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan.

Chen TH, Chen CJ, Yen MF, Lu SN, Sun CA, Huang GT, Yang PM, Lee HS, Duffy SW.

Int J Cancer. 2002 Mar 10;98(2):257-61.

PMID:
11857416
[PubMed - indexed for MEDLINE]
11.

Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.

Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.

Alcohol Clin Exp Res. 2003 Aug;27(8 Suppl):47S-51S.

PMID:
12960507
[PubMed - indexed for MEDLINE]
12.

Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.

N'Kontchou G, Paries J, Htar MT, Ganne-Carrie N, Costentin L, Grando-Lemaire V, Trinchet JC, Beaugrand M.

Clin Gastroenterol Hepatol. 2006 Aug;4(8):1062-8. Epub 2006 Jul 14.

PMID:
16844421
[PubMed - indexed for MEDLINE]
13.

Danish patients with alcoholic cirrhosis have a low risk of hepatocellular carcinoma thus raising questions about the utility of screening.

Wakim-Fleming J, Lopez R.

Evid Based Med. 2013 Aug;18(4):155-6. doi: 10.1136/eb-2012-100959. Epub 2012 Oct 20. No abstract available.

PMID:
23086563
[PubMed - indexed for MEDLINE]
14.

Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Fattovich G, Stroffolini T, Zagni I, Donato F.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50. Review.

PMID:
15508101
[PubMed - indexed for MEDLINE]
15.

Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis.

Toshikuni N, Izumi A, Nishino K, Inada N, Sakanoue R, Yamato R, Suehiro M, Kawanaka M, Yamada G.

J Gastroenterol Hepatol. 2009 Jul;24(7):1276-83. doi: 10.1111/j.1440-1746.2009.05851.x. Epub 2009 Apr 6.

PMID:
19486451
[PubMed - indexed for MEDLINE]
16.

Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: a nationwide population based cohort study.

Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H.

J Hepatol. 2011 Apr;54(4):760-4. doi: 10.1016/j.jhep.2010.07.016. Epub 2010 Sep 19.

PMID:
21126790
[PubMed - indexed for MEDLINE]
17.

[Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin].

Henrion J, Libon E, De Maeght S, Deltenre P, Schapira M, Ghilain JM, Maisin JM, Heller FR.

Gastroenterol Clin Biol. 2003 May;27(5):534-9. French.

PMID:
12843918
[PubMed - indexed for MEDLINE]
Free Article
18.

Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?

Nair S, Mason A, Eason J, Loss G, Perrillo RP.

Hepatology. 2002 Jul;36(1):150-5. Erratum in: Hepatology 2002 Sep;36(3):774.

PMID:
12085359
[PubMed - indexed for MEDLINE]
19.

Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.

Nahon P, Sutton A, Rufat P, Ziol M, Akouche H, Laguillier C, Charnaux N, Ganne-Carrié N, Grando-Lemaire V, N'Kontchou G, Trinchet JC, Gattegno L, Pessayre D, Beaugrand M.

Hepatology. 2009 Nov;50(5):1484-93. doi: 10.1002/hep.23187.

PMID:
19731237
[PubMed - indexed for MEDLINE]
20.

Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.

Yamanaka T, Shiraki K, Nakazaawa S, Okano H, Ito T, Deguchi M, Takase K, Nakano T.

Anticancer Res. 2001 Jul-Aug;21(4B):2937-40.

PMID:
11712790
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk